Lipocine Inc (LPCN)

Jan 06, 2026

How Lipocine Inc. stock reacts to global recession fears2026 world cup usa national team round of 16 young talents high defensive line expert forecast preview - ulpravda.ru

Jan 06, 2026

Dec 26, 2025

Critical Review: Lipocine (NASDAQ:LPCN) & Lyell Immunopharma (NASDAQ:LYEL) - Defense World

Dec 26, 2025

Dec 24, 2025

Lipocine reports ‘promising’ safety profile in Phase 3 trial of LPCN 1154 - MSN

Dec 24, 2025

Dec 24, 2025

Lipocine price target lowered to $7 from $8 at H.C. Wainwright - MSN

Dec 24, 2025

Dec 21, 2025

Aug PreEarnings: Can Lipocine Inc. stock outperform in 2025 bull marketQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - Улправда

Dec 21, 2025

Dec 21, 2025

Market Pulse: How Lipocine Inc. stock reacts to global recession fearsWeekly Trade Report & Long Hold Capital Preservation Tips - Улправда

Dec 21, 2025

Dec 20, 2025

Can Lipocine Inc. stock outperform in 2025 bull marketMarket Sentiment Report & Weekly High Return Stock Opportunities - Улправда

Dec 20, 2025

Dec 19, 2025

Does Lipocine Inc. stock trade at a discount to peersJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - Улправда

Dec 19, 2025

Dec 19, 2025

Return on equity % of Lipocine Inc. – BOATS:LPCN - TradingView — Track All Markets

Dec 19, 2025

Dec 19, 2025

Trend Review: Can Lipocine Inc. stock deliver consistent earnings growth2025 Valuation Update & Detailed Earnings Play Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How Lipocine Inc. stock performs in high volatility marketsJuly 2025 Snapshot & Fast Gain Stock Trading Tips - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Financial Review: Lipocine (NASDAQ:LPCN) vs. Astellas Pharma (OTCMKTS:ALPMY) - Defense World

Dec 19, 2025

Dec 16, 2025

Lipocine reaches 80% enrollment in postpartum depression drug trial By Investing.com - Investing.com Nigeria

Dec 16, 2025

Dec 16, 2025

Lipocine Advances Phase 3 Trial for PPD Treatment - TipRanks

Dec 16, 2025

Dec 16, 2025

Lipocine Inc Announces 80% Enrollment in PPD Phase 3 Study - TradingView — Track All Markets

Dec 16, 2025

Dec 16, 2025

Lipocine reaches 80% enrollment in postpartum depression drug trial - Investing.com India

Dec 16, 2025

Dec 16, 2025

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone - PR Newswire

Dec 16, 2025

Dec 15, 2025

Lipocine Inc. Announces Resignation of Jeffrey Fink as Director, Effective January 1, 2026 - marketscreener.com

Dec 15, 2025

Dec 15, 2025

Lipocine Earnings Notes - Trefis

Dec 15, 2025

Dec 11, 2025

Lipocine presents LPCN 2101 epilepsy candidate data at annual AES meeting - Investing.com UK

Dec 11, 2025

Dec 03, 2025

EBIT per share of Lipocine Inc. – BOATS:LPCN - TradingView

Dec 03, 2025

Dec 01, 2025

Lipocine (LPCN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

Nov 23, 2025

Lipocine Inc. (LPCN) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 23, 2025

Nov 21, 2025

Why hedge funds are buying Lipocine Inc. stockPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com

Nov 21, 2025

Nov 20, 2025

Can Lipocine Inc. stock sustain revenue growthJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com

Nov 20, 2025

Nov 20, 2025

Will Lipocine Inc. stock outperform value stocksMarket Risk Report & Low Risk High Win Rate Stock Picks - newser.com

Nov 20, 2025

Nov 19, 2025

Can Lipocine Inc. stock resist sector downturnsJuly 2025 Recap & AI Powered Market Trend Analysis - newser.com

Nov 19, 2025

Nov 19, 2025

How Lipocine Inc. stock reacts to inflationary pressuresOptions Play & Free Growth Oriented Trading Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Smart tools for monitoring Lipocine Inc.’s price actionEarnings Summary Report & Community Driven Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Lipocine Inc. stock a safe buy before earningsQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com

Nov 19, 2025

Nov 18, 2025

Lipocine reports positive safety review for PPD treatment in phase 3 trial - Investing.com Nigeria

Nov 18, 2025

Nov 18, 2025

Lipocine Announces Positive Interim Results for PPD Trial - TipRanks

Nov 18, 2025

Nov 18, 2025

[8-K] Lipocine Inc. Reports Material Event | LPCN SEC FilingForm 8-K - Stock Titan

Nov 18, 2025

Nov 18, 2025

Lipocine highlights promising interim safety profile in phase 3 trial of LPCN 1154 in postpartum depression (PPD) - MarketScreener

Nov 18, 2025

Nov 18, 2025

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) - The Herald Journal

Nov 18, 2025